Accelerating Discovery to FIH through Early Formulation Risk Assessments of Novel Biologics

• Inform candidate selection by evaluation of structural liabilities of lead candidates​ against target candidate profile
• Develop prototype product concepts to accelerate clinical formulation development

Suman Luthra, Director Discovery Pharmaceutical Sciences, Merck